Healthcare perspectives from The Economist Intelligence Unit

Color

#DB444B

Hero Carousel

Spotlight

Bringing healthcare to hard-hit areas in Bangladesh

YouTube

https://www.youtube.com/channel/UCQDMOSbJtqrtNzif5rS22OQ

Slideshare

http://www.slideshare.net/economistintelligenceunit

Pinterest

https://www.pinterest.com/theeiu/

Where’s hot and where’s not

This video shows a session of the The Pharma Summit 2011 exploring how markets are developing and creating new opportunities for the pharma industry and providing an informed viewpoint on the key issues facing the industry in this area.

On the future for research led-pharma

In this video, John Lechleite, President and Chief Executive Officer at Eli Lilly, opens The Pharma Summit 2011 by sharing his views on the future of the industry, and poses the question: can big pharma can continue to be research-led?

David Redfern: Pharma’s value proposition

David Redfern, CFO of GlaxoSmithKline, talks about how manifold challenges to the Pharma industry have led to a significant overhaul in the strategy of his organization.

Pharma Summit 2011 - Chair's closing remarks

In this video, Iain Scott, Managing Editor, Business Research at the Economist Intelligence Unit, provides his final remarks to close the The Pharma Summit 2011.

A fresh view on the future

In this video, part of The Risk Summit 2011, Mark Stevenson, Author of An Optimist's Tour of the Future, provided his view on the future and the risks it will bring with it.

On repositioning pharma for a new era

This panel of The Pharma Summit 2011, chaired by Peter Collins, Online Business and Finance Editor at The Economist, discusses the changing demands on the industry and how they can be reconciled with pharma’s commercial interests.

The case for personalised medicine

This session of The Pharma Summit 2011, chaired by Tom Standage, Digital Editor at The Economist, explores new developments in personalised medicine and discuss whether it can be made to pay its way.

Lessons on collaboration from North Karelia

One of the best known population-level prevention programmes took place in the North Karelia region of Finland: around 40 years ago the area’s population suffered from very high rates of non-communicable disease (NCD), even compared to Finland’s very high levels of the time.

JBS leverages strong real to grow internationally

JBS, the meatpacker, is one of Brazil’s big success stories. Through an aggressive campaign of acquisitions, the Brazilian company has become the world’s largest beef processor and among the largest poultry and pork processors.
The company, originally called Friboi, began modestly in 1953 with slaughterhouse capacity of just 5 heads per day. It only began to expand about 30 years later through acquisitions and investments to increase production. By 2002, its slaughter capacity was around 5,800 animals per day.

Brazil’s agribusiness companies

The profile of agribusiness companies in Brazil has changed dramatically over the past five to ten years. Previously, the so-called “A,B,C,D” multinational trading companies—Archer Daniel Midlands (ADM), Bunge, Cargill and Louis Dreyfus—dominated the market, riding the wave of rapid expansion in soybean and grain production in frontier regions such as Mato Grosso.

Enjoy in-depth insights and expert analysis - subscribe to our Perspectives newsletter, delivered every week